Axon Enterprise Stock Price Target and Analyst Ratings (NASDAQ:AXON)

Analyst Price Target for AXON

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$183.50

▲ +18.20% Upside Potential

This price target is based on 5 analysts offering 12 month price targets for Axon Enterprise in the last 3 months. The average price target is $183.50, with a high forecast of $200.00 and a low forecast of $170.00. The average price target represents a 18.20% upside from the last price of $155.25.

Buy

The current consensus among 5 investment analysts is to buy stock in Axon Enterprise.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
2 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

10/22/2019

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

1/20/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

4/19/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

7/18/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

10/16/2020

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

1/14/2021

0 strong buy ratings
4 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

3/15/2021

0 strong buy ratings
4 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

4/14/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
2/26/2021	Northland Securities	Initiated Coverage	Buy	$170.00	Medium	i Rating by Michael Latimore at Northland Securities
2/26/2021	Needham & Company LLC	Reiterated Rating	Buy		High	i
2/26/2021	Robert W. Baird	Boost Price Target	Outperform	$135.00 ➝ $200.00	High	i
2/12/2021	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$129.00 ➝ $179.00	Low	i
2/1/2021	Morgan Stanley	Initiated Coverage	Overweight	$185.00	Low	i
10/23/2019	JMP Securities	Reiterated Rating	Outperform	$28.00 ➝ $32.00	Low	i
2/11/2019	JMP Securities	Reiterated Rating	Buy	$6.00	Medium	i
12/17/2018	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$3.00	High	i
11/11/2018	Oppenheimer	Reiterated Rating	Hold		High	i Rating by Jay Olson at Oppenheimer Holdings Inc.
9/20/2018	Cowen	Reiterated Rating	Hold		Low	i
8/13/2018	HC Wainwright	Reiterated Rating	Buy	$7.00	Medium	i
7/9/2018	Oppenheimer	Reiterated Rating	Hold		Low	i Rating by Jay Olson at Oppenheimer Holdings Inc.
6/12/2018	Oppenheimer	Reiterated Rating	Hold		Low	i Rating by Jay Olson at Oppenheimer Holdings Inc.
6/11/2018	Jefferies Financial Group	Boost Price Target	Hold	$3.00 ➝ $5.00	High	i
6/7/2018	HC Wainwright	Reiterated Rating	Buy		High	i
6/6/2018	Oppenheimer	Reiterated Rating	Hold		High	i Rating by Jay Olson at Oppenheimer Holdings Inc.
6/6/2018	Chardan Capital	Reiterated Rating	Hold	$4.00	High	i Rating by G. Amusa at Chardan Capital
2/13/2018	Cowen	Reiterated Rating	Hold		High	i
2/13/2018	Oppenheimer	Reiterated Rating	Hold		High	i Rating by Jay Olson at Oppenheimer Holdings Inc.
1/12/2018	Cowen	Downgrade	Outperform ➝ Market Perform		High	i
1/10/2018	Chardan Capital	Upgrade	Sell ➝ Neutral	$2.50 ➝ $2.50	Low	i Rating by G. Amusa at Chardan Capital
12/21/2017	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$6.00	High	i Rating by Eun Yang at Jefferies Financial Group Inc.
12/1/2017	HC Wainwright	Reiterated Rating	Buy	$11.00	Medium	i
11/12/2017	Oppenheimer	Reiterated Rating	Hold		N/A	i
11/10/2017	Piper Jaffray Companies	Reiterated Rating	Hold		N/A	i
11/3/2017	Chardan Capital	Reiterated Rating	Sell	$3.00	N/A	i
11/1/2017	Robert W. Baird	Reiterated Rating	Hold	$6.00	N/A	i
10/19/2017	HC Wainwright	Reiterated Rating	Buy		N/A	i
10/6/2017	Chardan Capital	Reiterated Rating	Sell	$3.00	N/A	i
9/27/2017	HC Wainwright	Reiterated Rating	Buy	$11.00	Low	i
9/27/2017	Jefferies Financial Group	Reiterated Rating	Buy	$12.00	High	i
9/26/2017	Evercore ISI	Reiterated Rating	Outperform	$30.00 ➝ $9.00	High	i
9/26/2017	Cowen	Reiterated Rating	Outperform	$30.00 ➝ $25.00	High	i
9/26/2017	Oppenheimer	Downgrade	Outperform ➝ Market Perform		High	i
9/26/2017	JMP Securities	Reiterated Rating	Outperform	$36.00 ➝ $19.00	N/A	i
9/26/2017	Piper Jaffray Companies	Downgrade	Overweight ➝ Neutral	$32.00 ➝ $9.00	N/A	i
9/26/2017	UBS Group	Downgrade	Outperform ➝ Market Perform		N/A	i
9/26/2017	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$29.00 ➝ $6.00	N/A	i
9/25/2017	Oppenheimer	Reiterated Rating	Outperform ➝ Buy	$30.00	High	i
9/23/2017	Chardan Capital	Reiterated Rating	Sell ➝ Sell	$3.00	High	i
9/14/2017	Chardan Capital	Reiterated Rating	Sell	$8.00	Medium	i
9/8/2017	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$30.00	High	i
8/25/2017	Jefferies Financial Group	Set Price Target	Buy	$40.00	High	i
7/10/2017	Jefferies Financial Group	Initiated Coverage	Buy ➝ Buy	$40.00	Low	i
6/21/2017	Cowen	Reiterated Rating	Outperform	$30.00	Medium	i
6/14/2017	CIBC	Boost Price Target	Outperform ➝ Outperform	$26.00 ➝ $30.00	High	i
6/14/2017	Oppenheimer	Boost Price Target	Outperform	$26.00 ➝ $30.00	Medium	i
6/13/2017	Cowen	Reiterated Rating	Outperform	$22.00 ➝ $30.00	High	i
6/9/2017	Jefferies Financial Group	Reiterated Rating	Buy	$31.00	Low	i
4/18/2017	CIBC	Boost Price Target	Neutral	$30.00 ➝ $33.00	Low	i
4/18/2017	Jefferies Financial Group	Reiterated Rating	Buy	$31.00	Low	i
4/17/2017	Oppenheimer	Boost Price Target	Neutral	$30.00 ➝ $33.00	Low	i
4/14/2017	Oppenheimer	Reiterated Rating	Outperform	$20.00 ➝ $26.00	Low	i
4/12/2017	Piper Jaffray Companies	Reiterated Rating	Overweight	$32.00	Low	i
3/22/2017	Oppenheimer	Reiterated Rating	Buy		Medium	i
2/14/2017	HC Wainwright	Set Price Target	Buy	$35.00	N/A	i
2/14/2017	Cowen	Initiated Coverage	Outperform		N/A	i
2/13/2017	Piper Jaffray Companies	Reiterated Rating	Positive	$32.00	N/A	i
2/9/2017	Oppenheimer	Set Price Target	Buy	$20.00	N/A	i
2/3/2017	Cowen	Initiated Coverage	Outperform	$22.00	N/A	i
1/15/2017	Oppenheimer	Reiterated Rating	Outperform	$20.00	N/A	i
12/25/2016	Oppenheimer	Set Price Target	Buy	$20.00	N/A	i
12/20/2016	Robert W. Baird	Reiterated Rating	Positive	$29.00	N/A	i
12/20/2016	Laidlaw	Initiated Coverage	Sell	$7.50	N/A	i
12/18/2016	Piper Jaffray Companies	Set Price Target	Buy	$32.00	N/A	i
12/15/2016	Oppenheimer	Reiterated Rating	Buy	$20.00	N/A	i
12/6/2016	Oppenheimer	Initiated Coverage	Outperform	$20.00	N/A	i
11/25/2016	Robert W. Baird	Reiterated Rating	Outperform	$29.00	N/A	i
11/17/2016	Jefferies Financial Group	Reiterated Rating	Buy	$31.00	N/A	i
11/8/2016	HC Wainwright	Reiterated Rating	Buy		N/A	i
11/8/2016	JMP Securities	Reiterated Rating	Buy		N/A	i
10/24/2016	Robert W. Baird	Reiterated Rating	Outperform	$29.00	N/A	i
9/26/2016	Jefferies Financial Group	Reiterated Rating	Buy	$31.00	N/A	i
9/23/2016	Robert W. Baird	Reiterated Rating	Outperform	$29.00	N/A	i
9/23/2016	Evercore ISI	Reiterated Rating	Buy	$29.00	N/A	i
9/23/2016	Piper Jaffray Companies	Set Price Target	Buy	$32.00	N/A	i
8/17/2016	HC Wainwright	Reiterated Rating	Buy		N/A	i
8/16/2016	JMP Securities	Reiterated Rating	Outperform	$36.00	N/A	i
6/30/2016	SVB Leerink	Reiterated Rating	Buy		N/A	i
6/7/2016	HC Wainwright	Reiterated Rating	Buy		N/A	i
6/7/2016	SVB Leerink	Initiated Coverage	Outperform	$22.00	N/A	i Rating by P. Matteis at SVB Leerink LLC

(Data available from 4/14/2016 forward)

Axon Enterprise, Inc. engages in the development, manufacturing, and sale of conducted electrical weapons for personal defense. It operates through the TASER Weapons and Software and Sensors segments. The TASER Weapons segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Today's Range

Now: $155.25

$155.06

$155.56

50 Day Range

MA: $148.45

$133.45

$170.00

52 Week Range

Now: $155.25

$65.50

$212.37

Volume

408 shs

Average Volume

646,772 shs

Market Capitalization

$10.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Frequently Asked Questions

What sell-side analysts currently cover shares of Axon Enterprise?

The following equities research analysts have issued reports on Axon Enterprise in the last twelve months: JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Northland Securities, Robert W. Baird, and Zacks Investment Research.
View the latest analyst ratings for AXON.

What is the current price target for Axon Enterprise?

4 Wall Street analysts have set twelve-month price targets for Axon Enterprise in the last year. Their average twelve-month price target is $183.50, suggesting a possible upside of 18.2%. Robert W. Baird has the highest price target set, predicting AXON will reach $200.00 in the next twelve months. Northland Securities has the lowest price target set, forecasting a price of $170.00 for Axon Enterprise in the next year.
View the latest price targets for AXON.

What is the current consensus analyst rating for Axon Enterprise?

Axon Enterprise currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AXON will outperform the market and that investors should add to their positions of Axon Enterprise.
View the latest ratings for AXON.

What other companies compete with Axon Enterprise?

Other companies that are similar to Axon Enterprise include Microsoft, Oracle, ServiceNow, VMware, Fortinet, Proofpoint, C3.ai, Qualys, Commvault Systems, Progress Software and FalconStor Software.

How do I contact Axon Enterprise's investor relations team?

Axon Enterprise's physical mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The biotechnology company's listed phone number is (480) 991-0797. The official website for Axon Enterprise is www.axovant.com.

NASDAQ:AXON - Axon Enterprise Stock Price Target and Predictions

Analyst Price Target for AXON

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Axon Enterprise?

What is the current price target for Axon Enterprise?

What is the current consensus analyst rating for Axon Enterprise?

What other companies compete with Axon Enterprise?

How do I contact Axon Enterprise's investor relations team?